This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Third Affiliated Hospital, Third Military Medical University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Yu Han in Myocardial Ischemia Reperfusion
Introduction
Yu Han is an accomplished inventor based in Chongqing, China. He has made significant contributions to the field of medical science, particularly in the area of myocardial ischemia reperfusion injuries. His innovative work focuses on the application of irisin, a protein that has shown promise in reducing the adverse effects associated with myocardial ischemia.
Latest Patents
Yu Han holds a patent for the "Application of irisin in myocardial ischemia reperfusion." This invention discloses the use of irisin in the preparation of drugs aimed at preventing myocardial ischemia reperfusion injuries. Experimental results indicate that irisin can effectively decrease the myocardial infarction area caused by ischemia reperfusion. It also reduces the increase of various myocardial enzyme markers, such as lactate dehydrogenase (LDH), troponin (cTnI), and creatine kinase (CK), which are elevated during ischemia reperfusion. Furthermore, irisin helps mitigate inflammatory responses, myocardial apoptosis, and oxidative stress, thereby promoting better heart health.
Career Highlights
Yu Han is affiliated with the Third Affiliated Hospital of the Third Military Medical University. His work in this institution has allowed him to focus on groundbreaking research that has clinical significance in treating myocardial ischemia. His dedication to advancing medical science is evident through his innovative approaches and research findings.
Collaborations
Yu Han has collaborated with notable colleagues, including Chunyu Zeng and Zhen Wang. Their combined expertise has contributed to the success of their research initiatives and the development of effective treatments for myocardial ischemia.
Conclusion
Yu Han's contributions to the field of myocardial ischemia reperfusion through his innovative application of irisin highlight the importance of research in advancing medical treatments. His work not only demonstrates the potential of irisin in clinical settings but also underscores the significance of collaboration in scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile